4
Total investments
0
Early stage
1
Mid stage
2
Late stage
6y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Co-Managing Member of SPV that lead the Series C for Safeheal | Board member
Apr 2025
Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy.
Co-Managing Member of SPV into Tempo Therapeutics / Board Observer
Mar 2024
Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology.
Using MAP technology, Tempo is building functional tissue and organs within patients, in real time, to treat disease, and developing next-generation vaccine technologies that are shelf stable, stockpile-able, and protect against multiple diseases with a single injection. Our mission is to use MAP material technology to enable the future of medicine.
Co-Managing Member of SPV into Osteal Therapeutics | Board Member
Sep 2023
Osteal Therapeutics is a privately held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Consultant | Investor
Jul 2020
Babson Diagnostics™ is bringing medically-accurate BetterWay™ Blood Testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.
Experience · 7 entries
All (7)
Investments (4)
Board (3)
2025
Co-Managing Member of SPV that lead the Series C for Safeheal | Board member
Apr 2025
Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy.
2024
Co-Managing Member of SPV into Tempo Therapeutics / Board Observer
Mar 2024
Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology.
Using MAP technology, Tempo is building functional tissue and organs within patients, in real time, to treat disease, and developing next-generation vaccine technologies that are shelf stable, stockpile-able, and protect against multiple diseases with a single injection. Our mission is to use MAP material technology to enable the future of medicine.
2023
Co-Managing Member of SPV into Osteal Therapeutics | Board Member
Sep 2023
Osteal Therapeutics is a privately held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
2020
Consultant | Investor
Jul 2020
Babson Diagnostics™ is bringing medically-accurate BetterWay™ Blood Testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.
G
Genesis Merchant Capital
Co-Chairman & Senior Manager | Family Office Manager
Mar 2020
Show all 7 entries ↓
Investment activity
2020–2025 · 4 investments
Recent (last 2 years)Earlier
